Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

mureidomycin A

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Phosphoglycosyltransferases (PGTs) represent "gatekeeper" enzymes in complex glycan assembly pathways by catalyzing transfer of a… Expand
  • figure 1
  • figure 2
2010
2010
Two novel nucleosidyl–peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS 
  • figure 1
  • table 1
  • figure 2
  • figure 3
2008
2008
2,3-Diaminobutyric acid (DABA) is an unusual di-amino acid component of mureidomycin A, a member of the peptidylnucleoside… Expand
Highly Cited
1996
Highly Cited
1996
Using a continuous fluorescence-based enzyme assay, we have characterized the antibacterial agents tumicamycin and liposidomycin… Expand
Highly Cited
1996
Highly Cited
1996
Enzymes of the membrane cycle of reactions in bacterial peptidoglycan biosynthesis remain as unexploited potential targets for… Expand
Highly Cited
1991
Highly Cited
1991
Mureidomycin A (MRD), a novel peptidylnucleoside antibiotic with antipseudomonal activity, inhibited not only peptidoglycan… Expand
1965
1965
Mureidomycin A, a New Inhibitor of Bacterial Peptidoglycan Synthesis. Fujio Isono and Masatoshi Inukai… Expand